Immunoprotective activities of multiple chaperone proteins isolated from murine B-cell leukemia/lymphoma

Michael Graner, Amy Raymond, Davis Romney, Lin He, Luke Whitesell, Emmanuel Katsanis

Research output: Contribution to journalArticle

57 Scopus citations

Abstract

Although the use of tumor-derived heat shock/chaperone proteins (HSPs) as anticancer vaccines is gaining wider study and acceptance, there have thus far been no reports concerning chaperone antitumor activities against disseminated hematological malignancies. We have devised an efficient and effective method for purification of the chaperone proteins grp94/gp96, HSP90, HSP70, and calreticulin from harvested A20 murine leukemia/lymphoma tumor material. We have demonstrated that these purified proteins, when used as vaccines, can induce potent and specific immunity against a lethal tumor challenge. Individual chaperone proteins were differentially effective in their abilities to provide immune protection. The increase in survival generated by the most effective chaperone vaccine, HSP70, resulted from at least a 2-log reduction in tumor burden. Syngeneic granulocyte macrophage colony-stimulating factor producing fibroblasts were injected at the site of vaccination in an attempt to augment the immune response. Surprisingly, localized granulocyte macrophage colony-stimulating factor production inhibited the protective effects of chaperone vaccination. These studies provide evidence that chaperone proteins can be isolated from B-cell tumors and used effectively to immunize against disseminated lymphoid malignancies.

Original languageEnglish (US)
Pages (from-to)909-915
Number of pages7
JournalClinical Cancer Research
Volume6
Issue number3
StatePublished - Mar 1 2000

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Immunoprotective activities of multiple chaperone proteins isolated from murine B-cell leukemia/lymphoma'. Together they form a unique fingerprint.

  • Cite this